Search results
Results From The WOW.Com Content Network
Efforts to establish a medical cannabis program in Tennessee have failed in the Republican-dominated state legislature. Federal reclassification to Schedule 3 would, for the first time at the ...
The rescheduling of marijuana to a Schedule III drug would allow for further studies to be done. In a leaked HHS document , officials wrote to the DEA in support of rescheduling the drug.
The groups alleged that at least one high-level DEA official had communicated with opponents of marijuana rescheduling, helping them improve their chances of being chosen as a participant in the ...
After being proposed repeatedly since 1972, the U.S. Department of Justice initiated 2024 rulemaking to reschedule cannabis to Schedule III of the Controlled Substances Act. The majority of 2024 public comments supported descheduling, decriminalizing, or legalizing marijuana at the federal level. [1]
The year 2022 began with several United States cannabis reform proposals pre-filed in 2021 for the upcoming year's legislative session. Among the remaining prohibitionist states, legalization of adult use in Delaware and Oklahoma was considered most likely, and Maryland, Ohio, Pennsylvania and Rhode Island somewhat less likely; medical cannabis in Mississippi was called likely at the beginning ...
The Drug Enforcement Administration initiated a 2024 policy review to potentially reschedule marijuana as a Schedule III drug, amounting to "the agency's biggest policy change in more than 50 years". [4] Some hiring and retention policies in federal employment and the armed forces evolved during 2024.
The proposed federal change may have little affect in 24 states that already legalized recreational marijuana for adults, or in an additional 14 states that allow medical marijuana.
In 2018, U.S. states proposed or are expected to propose cannabis reform legislation for medical marijuana and non-medical adult use. State-level legalization remains at odds with cannabis' status as a Schedule I narcotic under the Controlled Substances Act at the Federal level, and the Cannabis policy of the Donald Trump administration appeared to become more hostile than that of the previous ...